"Curcumin, no matter how we measured it, was either comparable to sodium diclofenac or slightly better, " says co-author Ajay Goel, director of the Department of Epigenetics and Cancer Research at BaylorUniversityMedicalCenter in Dallas.
Other trial sites along with the University of Maryland MedicalCenter are Baylor College of Medicine, Cincinnati Children's Hospital MedicalCenter, Emory University, Saint Louis University, Seattle Group Health Cooperative, the University of Iowa, and Vanderbilt University.